SG11201707120PA - Use of ferric citrate in the treatment of iron-deficiency anemia - Google Patents
Use of ferric citrate in the treatment of iron-deficiency anemiaInfo
- Publication number
- SG11201707120PA SG11201707120PA SG11201707120PA SG11201707120PA SG11201707120PA SG 11201707120P A SG11201707120P A SG 11201707120PA SG 11201707120P A SG11201707120P A SG 11201707120PA SG 11201707120P A SG11201707120P A SG 11201707120PA SG 11201707120P A SG11201707120P A SG 11201707120PA
- Authority
- SG
- Singapore
- Prior art keywords
- iron
- treatment
- ferric citrate
- deficiency anemia
- anemia
- Prior art date
Links
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 title 1
- 229960002413 ferric citrate Drugs 0.000 title 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562127963P | 2015-03-04 | 2015-03-04 | |
| PCT/US2016/020575 WO2016141124A1 (en) | 2015-03-04 | 2016-03-03 | Use of ferric citrate in the treatment of iron-deficiency anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201707120PA true SG11201707120PA (en) | 2017-09-28 |
Family
ID=56848619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201707120PA SG11201707120PA (en) | 2015-03-04 | 2016-03-03 | Use of ferric citrate in the treatment of iron-deficiency anemia |
Country Status (15)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011011541A1 (en) | 2009-07-21 | 2011-01-27 | Henry Trong Le | Ferric citrate dosage forms |
| US20210085711A1 (en) * | 2017-09-19 | 2021-03-25 | Japan Tobacco Inc. | Use of ferric citrate in prevention and/or treatment of iron-deficiency anemia in hypermenorrhea patient and/or patient suffering from hypermenorrhea-associated gynecologic disease |
| FR3075601A1 (fr) * | 2017-12-21 | 2019-06-28 | Clarisse Le Court | Complements alimentaires et leur utilisation sur les menstruations |
| WO2020247935A1 (en) * | 2019-06-07 | 2020-12-10 | Arizona Board Of Regents On Behalf Of Arizona State University | Body fluid iron level panel analyzer |
| TW202313072A (zh) | 2021-05-27 | 2023-04-01 | 美商凱立克斯生物製藥股份有限公司 | 檸檬酸鐵之兒科調配物 |
| WO2023047424A1 (en) * | 2022-04-29 | 2023-03-30 | West Bengal Chemical Industries Limited | Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof |
| KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8093423B2 (en) * | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| JP4931352B2 (ja) * | 2004-01-14 | 2012-05-16 | 月桂冠株式会社 | 鉄補給剤及びその利用 |
| US20080113899A1 (en) * | 2004-01-14 | 2008-05-15 | Gekkeikan Sake Co., Ltd. | Iron Supplement and Utilization of the Same |
| MX2008002360A (es) * | 2005-08-18 | 2008-04-29 | Globoasia Llc | Compuestos organicos ferricos grado farmaceutico, uso de los mismos y metodos para elaborar los mismos. |
| US20120288531A1 (en) * | 2011-01-14 | 2012-11-15 | Shmuel Tuvia | pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
| MX2014015615A (es) * | 2012-06-21 | 2015-03-20 | Keryx Biopharmaceuticals Inc | Uso de citrato ferrico en el tratamiento de pacientes con enfermedad renal cronica. |
-
2016
- 2016-03-03 KR KR1020177027533A patent/KR20170123664A/ko not_active Ceased
- 2016-03-03 EA EA201791960A patent/EA201791960A1/ru unknown
- 2016-03-03 TW TW111133966A patent/TW202302083A/zh unknown
- 2016-03-03 AU AU2016226250A patent/AU2016226250B2/en not_active Expired - Fee Related
- 2016-03-03 SG SG11201707120PA patent/SG11201707120PA/en unknown
- 2016-03-03 HK HK18106104.0A patent/HK1246649A1/zh unknown
- 2016-03-03 US US15/553,348 patent/US20180071243A1/en not_active Abandoned
- 2016-03-03 TW TW105106564A patent/TWI812580B/zh active
- 2016-03-03 JP JP2017564757A patent/JP2018507260A/ja active Pending
- 2016-03-03 MX MX2017011169A patent/MX2017011169A/es unknown
- 2016-03-03 WO PCT/US2016/020575 patent/WO2016141124A1/en active Application Filing
- 2016-03-03 BR BR112017018963A patent/BR112017018963A2/pt not_active Application Discontinuation
- 2016-03-03 CA CA2978073A patent/CA2978073A1/en not_active Abandoned
- 2016-03-03 EP EP16759457.1A patent/EP3265077A4/en not_active Ceased
- 2016-03-03 HK HK18108472.0A patent/HK1248589A1/zh unknown
- 2016-03-03 CN CN201680025431.0A patent/CN107530310A/zh active Pending
-
2017
- 2017-08-23 IL IL254125A patent/IL254125A0/en unknown
-
2021
- 2021-01-26 JP JP2021010151A patent/JP2021091686A/ja active Pending
-
2022
- 2022-12-21 US US18/069,555 patent/US20240075006A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW201639558A (zh) | 2016-11-16 |
| MX2017011169A (es) | 2017-11-09 |
| IL254125A0 (en) | 2017-10-31 |
| EP3265077A1 (en) | 2018-01-10 |
| EA201791960A1 (ru) | 2018-01-31 |
| JP2021091686A (ja) | 2021-06-17 |
| HK1248589A1 (zh) | 2018-10-19 |
| US20240075006A1 (en) | 2024-03-07 |
| BR112017018963A2 (pt) | 2018-05-15 |
| CN107530310A (zh) | 2018-01-02 |
| WO2016141124A1 (en) | 2016-09-09 |
| CA2978073A1 (en) | 2016-09-09 |
| KR20170123664A (ko) | 2017-11-08 |
| US20180071243A1 (en) | 2018-03-15 |
| HK1246649A1 (zh) | 2018-09-14 |
| TW202302083A (zh) | 2023-01-16 |
| TWI812580B (zh) | 2023-08-21 |
| JP2018507260A (ja) | 2018-03-15 |
| EP3265077A4 (en) | 2018-10-24 |
| AU2016226250A1 (en) | 2017-09-28 |
| AU2016226250B2 (en) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267158B (en) | Amino-triazopyridine compounds and their use in cancer treatment | |
| IL310069B2 (en) | RAD1901 for use in cancer treatment | |
| IL251526A0 (en) | Use of cannabidiol in the treatment of multiple sclerosis complex | |
| ZA201803742B (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
| IL254125A0 (en) | Using iron citrate to treat iron deficiency anemia | |
| IL276733A (en) | Use of Aribolin in cancer treatment | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| IL251905B (en) | Epilimod for use in the treatment of kidney cancer | |
| GB201514021D0 (en) | Novel Pyridines and their use in the treatment of cancer | |
| RS61846B1 (sr) | Sredstva za upotrebu u lečenju glioma | |
| IL261648A (en) | Cinnolin-4-amine compounds and their use in treating cancer | |
| GB201514015D0 (en) | Novel pyridazinones and their use in the treatment of cancer | |
| IL259358A (en) | Bis-pyridazine compounds and their use in treating cancer | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| IL259205B (en) | Glycolipid compounds and their uses in the treatment of tumors | |
| RS65009B1 (sr) | Sastav za upotrebu u lečenju crevnih promena | |
| GB201514018D0 (en) | Novel tricyclic compounds and their use in the treatment of cancer | |
| EP3344661C0 (en) | IRON-POLYSACCHARIDE COMPLEXES AND PROCESSES FOR THEIR PREPARATION | |
| GB201510764D0 (en) | bis-Pyridazine compounds and their use in treating cancer |